Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AVENuE - Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study

NCT03617666 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT03617666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03617666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AVENuE - Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Unknown status
Start date
September 27, 2019
Completion date
May 30, 2025
Enrollment
49 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma